The decrease in the score of the 5% COS group was significant (p < 0.05).On Day 15, the scores of the 5% COS group and the FCZ group werehighly significantly decreased (p < 0.01) in comparison with the MC group. These findings indicate the striking, dose-dependent antidermatophytic activity of COS and suggest its potential for clinical development.